Harrow (HROW) Research & Development (2010 - 2026)

Harrow (HROW) recorded quarterly Research & Development of $5.9 million in Q1 2026, down 49.71% quarter-over-quarter from $11.7 million in Q4 2025, and up 94.81% on a YoY basis from $3.0 million in Q1 2025.

Harrow (HROW) Research & Development (2010 - 2026) Analysis & Trends

Harrow's Research & Development history runs 17 years deep, the most recent figure standing at $5.9 million for Q1 2026.

  • In Q1 2026, Research & Development rose 94.81% year-over-year to $5.9 million; the TTM figure through Mar 2026 stood at $23.8 million (up 81.65% YoY), while the FY2025 annual figure was $20.9 million, up 71.22% from the prior year.
  • Research & Development was $5.9 million for Q1 2026 at Harrow, down from $11.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $11.7 million in Q4 2025 to a low of $658000.0 in Q1 2022.
  • Historically, Research & Development has averaged $2.9 million across 5 years, with a median of $2.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 87.35% in 2022, then surged 374.54% in 2023.
  • A 5-year view of Research & Development shows it stood at $703000.0 in 2022, then surged by 374.54% to $3.3 million in 2023, then soared by 42.54% to $4.8 million in 2024, then soared by 146.54% to $11.7 million in 2025, then sank by 49.71% to $5.9 million in 2026.
  • The last three Research & Development figures came in at $5.9 million (Q1 2026), $11.7 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Harrow 1.23 Bn 1.14 Bn 27.05 Mn 5.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.90 Mn
Dec 31, 2025 11.72 Mn
Sep 30, 2025 3.32 Mn
Jun 30, 2025 2.87 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 4.76 Mn
Sep 30, 2024 2.27 Mn
Jun 30, 2024 3.05 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 3.34 Mn
Sep 30, 2023 1.42 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 734,000.00
Dec 31, 2022 703,000.00
Sep 30, 2022 775,000.00
Jun 30, 2022 914,000.00
Mar 31, 2022 658,000.00
Dec 31, 2021 3.94 Mn
Sep 30, 2021 6.13 Mn
Jun 30, 2021 425,000.00